Changes in the Crohn's Disease Activity Index and Safety of Administering Saccharomyces Boulardii in Patients with Crohn's Disease in Clinical Remission: A Single Hospital-based Retrospective Cohort Study.

Conclusions: In patients with CD in remission, S. boulardii appears to improve the CDAI, BMI, serum Hb, and total cholesterol level without safety issues. Further randomized controlled studies will be needed.
PMID: 33250507 [PubMed - as supplied by publisher]

Source: Korean J Gastroenter... - November 30, 2020 Category: Gastroenterology Authors: Oh GM, Moon W, Seo KI, Jung K, Kim JH, Kim SE, Park MI, Park SJ Tags: Korean J Gastroenterol Source Type: research